AlphaFold predicted structure
TXN2 · Q99757

Mean pLDDT
84.0/ 100
Confident
166 residues
Confidence breakdown
- Very high(≥ 90)65%
- Confident(70–90)1%
- Low(50–70)33%
- Very low(< 50)2%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
thioredoxin 2
Annotations refreshed 9 hours ago.
Moderate Evidence (Amber)
Fetal anomalies
BIALLELIC, autosomal or pseudoautosomalPossible mitochondrial disorder - nuclear genes
BIALLELIC, autosomal or pseudoautosomalEarly onset or syndromic epilepsy
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalMitochondrial disorders
BIALLELIC, autosomal or pseudoautosomalcombined oxidative phosphorylation defect type 15
lung carcinoma
lung cancer
acute respiratory distress syndrome
frozen shoulder
hydrops fetalis
metabolic dysfunction-associated steatotic liver disease
endometriosis
non-small cell lung carcinoma
acquired polycythemia vera
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Thioredoxin, mitochondrial
Important for the control of mitochondrial reactive oxygen species homeostasis, apoptosis regulation and cell viability (PubMed:12032145, PubMed:12080052, PubMed:26626369) Is involved in various redox reactions including the reduction of protein disulfide bonds, through the reversible oxidation of its active center dithiol to a disulfide (By similarity)
TXN2 · Q99757

Mean pLDDT
84.0/ 100
Confident
166 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0